NYSE •
Healthcare •
Biotechnology •
Quote as of 08/21/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNYSE
Market Capitalization4,417.34 mln
Float31.84 mln
Earnings Date08/11/2026
1-Year Forecast
164
Exceptional upside
Relative Strength
5
/ 100
Severely lagging
Debt / Equity
0.00
Debt-free
ROE
-29.41
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Veradermics is a New Haven, Connecticut-based medical company founded in 2019 that creates new treatments for skin and hair conditions in both adults and children. Its pipeline includes an oral non-hormonal pill for chronic hair loss, a dissolving patch that delivers immunotherapy for common warts, and targeted therapies for alopecia areata and molluscum contagiosum. The company works closely with dermatologists, clinicians, and medical researchers to bring these solutions to patients.
